Ameritox(R) to Build New Processing Facility in Greensboro, North Carolina
BALTIMORE, Oct. 21 -- Ameritox, the U.S. leader in pain medication monitoring solutions, today announced plans to build a second laboratory facility in Greensboro, North Carolina.
Ameritox, which provides laboratory services and practice management tools to help clinicians coordinate the care of their chronic pain patients, is scheduled to open the Greensboro facility in 2010. The Ameritox Greensboro Laboratory will offer the increased processing capacity to match the company's rapid growth and its commitment to helping physicians enhance treatment outcomes. Ameritox currently operates a laboratory in Midland, Texas, which performs screening and confirmatory testing on hundreds of thousands of specimens annually through its proprietary Rx Guardian(SM) methodology.
"We are very excited about locating our laboratory in Greensboro, North Carolina. The state offers a diverse and talented work force, an abundance of top tier educational institutions, and is well situated to help our company continue to grow," said Ancelmo E. Lopes, Chief Executive Officer of Ameritox. "Its opening will help us provide more physicians and patients with laboratory information that goes beyond standard urine drug testing to help them determine if patients are taking their medications as directed – ultimately leading to enhanced patient care."
Ameritox plans to hire 228 employees once the laboratory is fully operational in 2010.
Ameritox is the nation's leader in pain medication monitoring solutions(SM), offering specialized laboratory testing and reporting services. Ameritox's expertise and innovative science provides physicians with insights and support to enhance and optimize the care of chronic pain patients. Ameritox offers Rx Guardian(SM), the most thorough and personalized lab service available and the only pain medication testing program with a proprietary methodology to help physicians assess whether patients are taking their pain medication as directed. Medication monitoring helps physicians make more informed clinical decisions and manage the risks and complexities associated with prescribing pain medications. Ameritox is headquartered in Baltimore, MD, with laboratory facilities in Midland, TX and a second laboratory opening early 2010 in Greensboro, NC.
AMERITOX, the AMERITOX logo, RX GUARDIAN and PROTECT YOUR PATIENTS, PROTECT YOUR PRACTICE are trademarks of Ameritox.